Cynosure Inc (CYNO) Files Form 4 Insider Selling : Michael R Davin Sells 74,729 Shares

Cynosure Inc (CYNO): Michael R Davin , Chairman and CEO of Cynosure Inc sold 74,729 shares on Apr 15, 2016. The Insider selling transaction was reported by the company on Apr 19, 2016 to the Securities and Exchange Commission. The shares were sold at $45.25 per share for a total value of $3,386,214.75 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 18, 2016, Douglas J Delaney (Executive VP, Sales) sold 24,488 shares at $45.02 per share price.On Apr 18, 2016, Timothy W Baker (President and CFO) sold 39,857 shares at $45.02 per share price.Also, On Apr 18, 2016, Michael R Davin (Chairman and CEO) sold 61,377 shares at $45.01 per share price.On Jun 2, 2015, Ettore V Biagioni (director) sold 24,000 shares at $36.25 per share price.

Cynosure: On Monday, Apr 18, 2016 heightened volatility was witnessed in Cynosure which led to swings in the share price. The shares opened for trading at $45.04 and hit $46.47 on the upside , eventually ending the session at $45.08, with a gain of 0.22% or 0.1 points. The heightened volatility saw the trading volume jump to 7,86,355 shares. The 52-week high of the share price is $46.6 and the company has a market cap of $1,036 M . The 52-week low of the share price is at $29.

Cynosure Money Flow Index Chart

Currently the company Insiders own 3.4% of Cynosure shares according to the proxy statements.Institutional Investors own 93.84% of Cynosure shares.

Cynosure Inc. develops and markets aesthetic treatment systems that enable plastic surgeons dermatologists and other medical practitioners to perform procedures to remove hair treat vascular and benign pigmented lesions remove multi-colored tattoos revitalize the skin liquefy and remove unwanted fat through laser lipolysis reduce cellulite clear nails infected by toe fungus ablate sweat glands and improve vaginal health. The Company also markets radiofrequency (RF) energy sourced medical devices for precision surgical applications such as facial plastic and general surgery; gynecology; ear nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry and proctology. The Company offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies.

Leave a Reply

Cynosure - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cynosure. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.